165 related articles for article (PubMed ID: 36746781)
1. Risk of readmission among individuals with cannabis use disorder during a 15-year cohort study: the impact of socio-economic factors and psychiatric comorbidity.
Rabiee R; Sjöqvist H; Agardh E; Lundin A; Danielsson AK
Addiction; 2023 Jul; 118(7):1295-1306. PubMed ID: 36746781
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use disorder in relation to socioeconomic factors and psychiatric comorbidity: A cluster analysis of three million individuals born in 1970-2000.
Rabiee R; Lundin A; Agardh E; Allebeck P; Danielsson AK
Scand J Public Health; 2023 Feb; 51(1):82-89. PubMed ID: 36120841
[TBL] [Abstract][Full Text] [Related]
3. Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder.
Jefsen OH; Erlangsen A; Nordentoft M; Hjorthøj C
JAMA Psychiatry; 2023 Aug; 80(8):803-810. PubMed ID: 37223912
[TBL] [Abstract][Full Text] [Related]
4. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada.
Bahji A; Hathaway J; Adams D; Crockford D; Edelman EJ; Stein MD; Patten SB
Addiction; 2024 Jan; 119(1):137-148. PubMed ID: 37766508
[TBL] [Abstract][Full Text] [Related]
6. Association of Cannabis Use With Self-harm and Mortality Risk Among Youths With Mood Disorders.
Fontanella CA; Steelesmith DL; Brock G; Bridge JA; Campo JV; Fristad MA
JAMA Pediatr; 2021 Apr; 175(4):377-384. PubMed ID: 33464286
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
[No Abstract] [Full Text] [Related]
8. Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.
Quick CR; Conway KP; Swendsen J; Stapp EK; Cui L; Merikangas KR
JAMA Psychiatry; 2022 Jul; 79(7):727-735. PubMed ID: 35648395
[TBL] [Abstract][Full Text] [Related]
9. Association between cannabis use disorder and schizophrenia stronger in young males than in females.
Hjorthøj C; Compton W; Starzer M; Nordholm D; Einstein E; Erlangsen A; Nordentoft M; Volkow ND; Han B
Psychol Med; 2023 Nov; 53(15):7322-7328. PubMed ID: 37140715
[TBL] [Abstract][Full Text] [Related]
10. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
[TBL] [Abstract][Full Text] [Related]
11. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States.
Patel RS; Goyal H; Satodiya R; Tankersley WE
Subst Use Misuse; 2020; 55(2):281-290. PubMed ID: 31573379
[No Abstract] [Full Text] [Related]
12. State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019.
Hasin DS; Wall MM; Choi CJ; Alschuler DM; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; Mannes Z; Sherman S; Saxon AJ
JAMA Psychiatry; 2023 Apr; 80(4):380-388. PubMed ID: 36857036
[TBL] [Abstract][Full Text] [Related]
13. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States.
Kerridge BT; Mauro PM; Chou SP; Saha TD; Pickering RP; Fan AZ; Grant BF; Hasin DS
Drug Alcohol Depend; 2017 Dec; 181():223-228. PubMed ID: 29107786
[TBL] [Abstract][Full Text] [Related]
14. Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders.
Rømer Thomsen K; Thylstrup B; Pedersen MM; Pedersen MU; Simonsen E; Hesse M
Schizophr Res; 2018 May; 195():495-500. PubMed ID: 28965780
[TBL] [Abstract][Full Text] [Related]
15. Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy.
Meinhofer A; Hinde JM; Keyes KM; Lugo-Candelas C
JAMA Psychiatry; 2022 Jan; 79(1):50-58. PubMed ID: 34730782
[TBL] [Abstract][Full Text] [Related]
16. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder.
Hjorthøj C; Uddin MJ; Wimberley T; Dalsgaard S; Hougaard DM; Børglum A; Werge T; Nordentoft M
Psychol Med; 2021 Feb; 51(3):479-484. PubMed ID: 31813396
[TBL] [Abstract][Full Text] [Related]
17. Parental transmission of risk for cannabis use disorders to offspring.
Kosty DB; Farmer RF; Seeley JR; Gau JM; Duncan SC; Lewinsohn PM
Addiction; 2015 Jul; 110(7):1110-7. PubMed ID: 25754308
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness.
Kozak K; H Smith P; Lowe DJE; Weinberger AH; Cooper ZD; Rabin RA; George TP
Am J Drug Alcohol Abuse; 2021 Sep; 47(5):535-547. PubMed ID: 34280058
[TBL] [Abstract][Full Text] [Related]
19. Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality disorder.
Østergaard MLD; Nordentoft M; Hjorthøj C
Addiction; 2017 Jul; 112(7):1250-1259. PubMed ID: 28192643
[TBL] [Abstract][Full Text] [Related]
20. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
